One of america's oldest malls is closing
- HEALTH
- February 25, 2015

New Delhi [India], September 27: In a significant development for India’s animal health sector, veterinary vaccine manufacturers have come together to announce the formation of the Veterinary Vaccine India Manufacturers Association (VVIMA). VVIMA is a non-government, not-for-profit organization that will serve as the collective voice of India’s veterinary vaccine manufacturers. The association will actively collaborate
READ MORE
Hyderabad (Telangana) [India], September 25: Nearly 50% of Indian women aged between 35 and 49 years are now classified as overweight or obese, according to a recent study reported by The Times of India. The findings raise critical questions about women’s reproductive health and fertility outcomes, especially as more couples in urban India turn to
READ MORE
Hyderabad (Telangana) [India], September 25: Fertility preservation is no longer a subject confined to medical textbooks and oncology wards—it is now part of mainstream conversations among India’s urban, career-driven women. One procedure leading this change is egg freezing, and guiding this shift with expertise and compassion is Dr S. Vyjayanthi, Director of MotherToBe Fertility Centre and
READ MORE
Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted therapy for HER2-positive breast cancer demonstrates the synergy between two healthcare leaders committed to advanced cancer treatment accessibility. Innovation Meets
READ MORE
New Delhi [India], September 25: With breast cancer on the rise and 1 in 8 Indian women at risk, a landmark initiative blends knowledge, self-advocacy, and risk assessment to transform how India faces its most common women’s cancer. After winning international recognition for pioneering a breast cancer awareness program in South Africa, Phylaxis.ai® now brings an
READ MORE
Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. Developed through a semi-exclusive collaboration with Enzene Biosciences Limited, this breakthrough aims to reduce the economic barriers faced by thousands of HER2-positive breast cancer patients.
READ MORE